Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Kushner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical Sciences|February 15, 2011
Examining the impact of excipient material property variation on drug product quality attributes: a quality-by-design study for a roller compacted, immediate release tabletJoseph Kushner, Beth A Langdon, Jon I Hiller, et al.
AAPS Pharmscitech|December 1, 2021
Developing a Biorelevant Dissolution Method for an Extrudable Core System (ECS) Osmotic TabletRaymond Chen, Andrew Blanchard, Joseph Kushner, et al.
Drug Development and Industrial Pharmacy|May 2, 2018
Quantifying and reducing powder shear sensitivity when manufacturing capsules with lubricantsDaniel Blackwood, William Ketterhagen, John Kresevic, et al.
Journal of Clinical Pharmacology|March 13, 2016
Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of FoodManisha Lamba, Rong Wang, Tracey Fletcher, et al.
The Journal of Investigative Dermatology|June 8, 2007
Dual-channel two-photon microscopy study of transdermal transport in skin treated with low-frequency ultrasound and a chemical enhancerJoseph Kushner, Daekeun Kim, Peter T C So, et al.
Clinical Pharmacology in Drug Development|May 13, 2022
Bridging Efficacy of Tofacitinib Immediate-Release to Extended-Release Formulations for Treatment of Ulcerative Colitis: Application of a Model-Informed Drug Development ApproachArnab Mukherjee, Shinichi Tsuchiwata, Cheng Chang, et al.
Journal of Pharmaceutical Sciences|December 31, 2013
A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributesJoseph Kushner, Beth A Langdon, Ian Hicks, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 22, 2019
Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technologyJoseph Kushner, Manisha Lamba, Thomas Stock, et al.
Clinical Pharmacology and Therapeutics|May 27, 2024
Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified-Release Dosage FormVivek Purohit, Kazuko Sagawa, Hao-Jui Hsu, et al.
Molecular Pharmaceutics|April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory SubmissionsSumit Arora, Xavier Pepin, Masoud Jamei, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical Sciences|February 15, 2011
Examining the impact of excipient material property variation on drug product quality attributes: a quality-by-design study for a roller compacted, immediate release tabletJoseph Kushner, Beth A Langdon, Jon I Hiller, et al.
AAPS Pharmscitech|December 1, 2021
Developing a Biorelevant Dissolution Method for an Extrudable Core System (ECS) Osmotic TabletRaymond Chen, Andrew Blanchard, Joseph Kushner, et al.
Drug Development and Industrial Pharmacy|May 2, 2018
Quantifying and reducing powder shear sensitivity when manufacturing capsules with lubricantsDaniel Blackwood, William Ketterhagen, John Kresevic, et al.
Journal of Clinical Pharmacology|March 13, 2016
Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of FoodManisha Lamba, Rong Wang, Tracey Fletcher, et al.
The Journal of Investigative Dermatology|June 8, 2007
Dual-channel two-photon microscopy study of transdermal transport in skin treated with low-frequency ultrasound and a chemical enhancerJoseph Kushner, Daekeun Kim, Peter T C So, et al.
Clinical Pharmacology in Drug Development|May 13, 2022
Bridging Efficacy of Tofacitinib Immediate-Release to Extended-Release Formulations for Treatment of Ulcerative Colitis: Application of a Model-Informed Drug Development ApproachArnab Mukherjee, Shinichi Tsuchiwata, Cheng Chang, et al.
Journal of Pharmaceutical Sciences|December 31, 2013
A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributesJoseph Kushner, Beth A Langdon, Ian Hicks, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 22, 2019
Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technologyJoseph Kushner, Manisha Lamba, Thomas Stock, et al.
Clinical Pharmacology and Therapeutics|May 27, 2024
Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified-Release Dosage FormVivek Purohit, Kazuko Sagawa, Hao-Jui Hsu, et al.
Molecular Pharmaceutics|April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory SubmissionsSumit Arora, Xavier Pepin, Masoud Jamei, et al.
Pageof 2